ProKidney (MEX:PROK) Construction In Progress : MXN21.87 Mil (As of Jun. 2024)

View and export this data going back to 2022. Start your Free Trial

What is ProKidney Construction In Progress?

ProKidney's quarterly construction in progress increased from Dec. 2023 (MXN148.37 Mil) to Mar. 2024 (MXN150.64 Mil) but then declined from Mar. 2024 (MXN150.64 Mil) to Jun. 2024 (MXN21.87 Mil).

ProKidney's annual construction in progress increased from Dec. 2021 (MXN7.20 Mil) to Dec. 2022 (MXN31.47 Mil) and increased from Dec. 2022 (MXN31.47 Mil) to Dec. 2023 (MXN148.37 Mil).

ProKidney Construction In Progress Historical Data

The historical data trend for ProKidney's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ProKidney Construction In Progress Chart

ProKidney Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Construction In Progress

156.23

7.20

31.47

148.37

ProKidney Quarterly Data
	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Construction In Progress	Get a 7-Day Free Trial										100.53	147.83	148.37	150.64	21.87

ProKidney Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

ProKidney Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ProKidney Corp (MEX:PROK) » Definitions » Construction In Progress

Comparable Companies

Traded in Other Exchanges

PROK:USA

Address

2000 Frontis Plaza Boulevard, Suite 250, Winston-Salem, NC, USA, 27103

Website

https://www.prokidney.com

ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's own cells isolated from the patient intended for treatment. Its lead product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's own renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease.